ACT Capital Management »

Cytokinetics shares owned by ACT Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 65k 63.54

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics